Showing results (441-450 of 464) with videos related to
Sort By:
Pageof 47
Blood|March 1, 1981
Bone marrow transplantation for refractory acute leukemia in 34 patients with identical twinsA Fefer, M A Cheever, E D Thomas, et al.Human Pathology|January 1, 1983
The predictive value of elevated labial saliva sodium concentration: its relation to labial gland pathology in bone marrow transplant recipientsK T Izutsu, M M Schubert, E L Truelove, et al.Leukemia|August 13, 2014
Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer CenterR B Walter, M Othus, A K Burnett, et al.Transplantation|May 1, 1983
Disordered salivary immunoglobulin secretion and sodium transport in human chronic graft-versus-host diseaseK T Izutsu, K M Sullivan, M M Schubert, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescueS Y Liu, J F Eary, S H Petersdorf, et al.Leukemia|August 30, 2002
Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin)R A Larson, M Boogaerts, E Estey, et al.Bone Marrow Transplantation|November 18, 1998
High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancerL A Holmberg, T Demirer, S Rowley, et al.Bone Marrow Transplantation|June 1, 1997
High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancerW I Bensinger, K S Schiffman, L Holmberg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myelomaW I Bensinger, S D Rowley, T Demirer, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 14, 1997
Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine?R Storb, W Leisenring, C Anasetti, et al.Pageof 47